COSM (Cosmos Health) Receivables Turnover: 0.95 (As of Mar. 2026)


COSM Cosmos Health Inc COSM
29 GF Score
Price $0.24
GF Value $0.36
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cosmos Health Receivables Turnover?

Cosmos Health COSM +17.09% 29 Receivables Turnover is 0.95 as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 116 Medical Distribution companies, Cosmos Health ranks worse than 61.21% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Cosmos Health's Revenue for the three months ended in Mar. 2026 was $17.93 Mil. Cosmos Health's average Accounts Receivable for the three months ended in Mar. 2026 was $18.91 Mil. Hence, Cosmos Health's Receivables Turnover for the three months ended in Mar. 2026 was 0.95.


Cosmos Health  (NAS:COSM) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Cosmos Health Receivables Turnover Related Terms


Cosmos Health Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Cosmos Health's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmos Health Receivables Turnover Chart

Cosmos Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 2.01 2.46 3.28 3.94

Cosmos Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 0.99 1.02 1.05 0.95

COSM vs HKPD, SNYR, YI: Receivables Turnover Comparison

For the Medical Distribution subindustry, Cosmos Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmos Health Receivables Turnover vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cosmos Health's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Cosmos Health's Receivables Turnover falls into.


COSM
29GF Score
Cosmos Health Inc COSM
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmos Health Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Cosmos Health's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=65.272 / ((13.478 + 19.629) / 2 )
=65.272 / 16.5535
=3.94

Cosmos Health's Receivables Turnover for the quarter that ended in Mar. 2026 is calculated as

Receivables Turnover (Q: Mar. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Mar. 2026 ) / ((Accounts Receivable (Q: Dec. 2025 ) + Accounts Receivable (Q: Mar. 2026 )) / count )
=17.928 / ((19.629 + 18.187) / 2 )
=17.928 / 18.908
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.95 mean?
Cosmos Health (COSM) has a Receivables Turnover of 0.95 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #71 out of 116 companies in the Medical Distribution industry, placing it in the top 61.2%.
Is Cosmos Health's Receivables Turnover too high?
Cosmos Health's current Receivables Turnover is 0.95. The Medical Distribution industry median Receivables Turnover is 4.55. Cosmos Health's value of 0.95 is 79.1% below this industry median. Based on the distribution chart, Cosmos Health ranks #71 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Receivables Turnover compare to HKPD and SNYR?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #71 out of 116 companies for Receivables Turnover. This places Cosmos Health in the lower half of its industry. The industry median Receivables Turnover is 4.55. Cosmos Health's value of 0.95 is 79.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.55, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current Receivables Turnover of 0.95 is 79.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Receivables Turnover is 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.24 — trading 34.1% below its estimated fair value. The current Receivables Turnover is 0.95 and 79.1% below the Medical Distribution industry median of 4.55. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Cosmos Health (COSM), the current Receivables Turnover is 0.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmos Health (COSM) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued. The current stock price of $0.24 is trading 34.1% below its estimated GF Value™ of $0.36. GuruFocus considers Cosmos Health to be Possible Value Trap.

Key valuation signals for COSM:

  • Receivables Turnover: 0.95
  • GF Value™: $0.36 vs. price of $0.24 (34.1% below fair value)
  • GF Score™: 29/100 with 6 warning signs
  • Industry Position: 79.1% below the Medical Distribution median (#71 of 116)

No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cosmos Health Business Description

Other Exchanges V67A:Germany
Address 5 Agiou Georgiou Street, Pilea, Thessaloniki, GRC, 55438
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score

Get the complete analysis for COSM

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.24
Price
$0.36
GF Value